Hyderabad-based Natco Pharma Ltd said it launched the generic version of Anastrazole 1 mg tablets in the US through the company’s marketing partners.
Anastrazole is used in the treatment of breast cancers and the market for this product in the US is expected to be in the region of $750 million per annum, according to a company press release on Tuesday.
On Tuesday, Natco Pharma shares fell 3.8% to Rs203 on the BSE, where the benchmark Sensex declined 1.4% to 17534 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
